Patents by Inventor Kaori Nishizaki

Kaori Nishizaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prostaglandin derivative-containing aqueous liquid preparation
    Patent number: 8044104
    Abstract: Provided is an aqueous liquid preparation comprising: (a) any one of a prostaglandin derivative being represented by the following formula (I), a pharmaceutically acceptable salt thereof and a hydrate thereof; and (b) at least one polyol of glycerin, propylene glycol, dipropylene glycol and 1,3-butylene glycol.
    Type: Grant
    Filed: May 28, 2008
    Date of Patent: October 25, 2011
    Assignee: Taisho Pharmaceutical Co., Ltd
    Inventors: Kaori Nishizaki, Takayuki Sato, Kentaro Goto, Kuniaki Ishii
  • Ointment
    Patent number: 7888392
    Abstract: An ointment containing a compound represented by formula (I): [wherein R1 represents any group of a group represented by the formula: —(CH2)4—S—CH2—CO2H, a group represented by the formula: —(CH2)4—S—CH2—CO2CH3, a group represented by the formula: —(CH2)4—C?C—CO2H, a group represented by the formula: —CH2—S—(CH2)2—S—CH2—CO2H, and a group represented by the formula: —CH2—S—(CH2)4—CO2H], and an oleaginous base, is an ointment containing a compound which is effective for atopic symptoms, and is an ointment having low skin irritancy and excellent storage stability, thus, can be used as a pharmaceutical product effective for the pruritus caused by atopy or the like.
    Type: Grant
    Filed: February 14, 2006
    Date of Patent: February 15, 2011
    Assignee: Taisho Pharmaceutical Co., Ltd.
    Inventors: Akihiko Kamiya, Yoshie Shinohara, Takayuki Sato, Kaori Nishizaki, Akiko Miwa, Takatoshi Iida
  • PROSTAGLANDIN DERIATIVE-CONTAINING AQUEOUS LIQUID PREPARATION
    Publication number: 20100204331
    Abstract: Provided is an aqueous liquid preparation comprising: (a) any one of a prostaglandin derivative being represented by the following formula (I), a pharmaceutically acceptable salt thereof and a hydrate thereof; and (b) at least one polyol of glycerin, propylene glycol, dipropylene glycol and 1,3-butylene glycol.
    Type: Application
    Filed: May 28, 2008
    Publication date: August 12, 2010
    Applicant: TAISHO PHARMACEUTICAL CO., LTD.
    Inventors: Kaori Nishizaki, Takayuki Sato, Kentaro Goto, Kuniaki Ishii
  • Ointment
    Publication number: 20080167379
    Abstract: An ointment containing a compound represented by formula (I): [wherein R1 represents any group of a group represented by the formula: —(CH2)4—S—CH2—CO2H, a group represented by the formula: —(CH2)4—S—CH2—CO2CH3, a group represented by the formula: —(CH2)4—C?C—CO2H, a group represented by the formula: —CH2—S—(CH2)2—S—CH2—CO2H, and a group represented by the formula: —CH2—S—(CH2)4—CO2H], and an oleaginous base, is an ointment containing a compound which is effective for atopic symptoms, and is an ointment having low skin irritancy and excellent storage stability, thus, can be used as a pharmaceutical product effective for the pruritus caused by atopy or the like.
    Type: Application
    Filed: February 14, 2006
    Publication date: July 10, 2008
    Applicant: TAISHO PHARMACEUTICAL CO., LTD.
    Inventors: Akihiko Kamiya, Yoshie Shinohara, Takayuki Sato, Kaori Nishizaki, Akiko Miwa, Takatoshi Iida